Published 01:52 IST, September 12th 2020
DCGI orders Serum Institute of India to suspend recruitment for Oxford COVID-19 vaccine trials
Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.
null | Image:
self
- Listen to this article
- 3 min read
Advertisement
01:52 IST, September 12th 2020